Thus, further investigation is warranted to determine whether MAMs and IP3R2-GRP75-VDAC1 complex in myocardial cells could serve as novel clinical targets for pharmacological intervention in myocardial infarction, by modulating intracellular calcium homeostasis after AMI. This evidence concerns the gene ITPR2 and myocardial infarction.